The PSA nadir that indicates potential cure after radiotherapy for prostate cancer von Critz, Frank A., Keith Levinson, A., Hamilton Williams, W., Holladay, David A., Holladay, Clinton T., Klein, Eric A., Kupelian, Patrick J.

Volltext

African American Men with Prostate Cancer Treated by Simultaneous Irradiation von Williams, W. Hamilton, Critz, Frank A., Benton, James B., Levinson, Keith, Falconer, Walter, Harrison, Emerson, Holladay, Clinton T., Holladay, David A.

Volltext

Post-treatment PSA ≤ 0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques von Critz, Frank A, Williams, W.Hamilton, Holladay, Clinton T, Levinson, A.Keith, Benton, James B, Holladay, David A, Schnell, Frederick J, Maxa, Leela S, Shrake, Philip D

Volltext

Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer von Critz, Frank A., Levinson, Keith, Hamilton Williams, W., Holladay, David, Holladay, Clinton, Griffin, Vivian

Volltext

1008 10-year PSA monitored followup in surgically staged prostate cancer patients treated with irradiation von Critz, Frank A., Williams, W.Hamilton, Levinson, Keith, Holladay, David, Clinton

Volltext